Literature DB >> 9135141

Roles of the influenza virus polymerase and nucleoprotein in forming a functional RNP structure.

K Klumpp1, R W Ruigrok, F Baudin.   

Abstract

Influenza virus transcription and replication is performed by ribonucleoprotein particles (RNPs). They consist of an RNA molecule covered with many copies of nucleoprotein (NP) and carry a trimeric RNA polymerase complex. RNA modification analysis and electron microscopy performed on native RNPs suggest that the polymerase forms a complex with both conserved viral RNA (vRNA) ends, whereas NP binding exposes the RNA bases to the solvent. After chemical removal of the polymerase, the bases at the vRNA extremities become reactive to modification and the vRNPs behave as structures with free ends, as judged from the observation of salt-induced conformational changes by electron microscopy. The vRNA appears to be completely single-stranded in polymerase-free RNPs despite a partial, inverted complementarity of the vRNA ends. The absence of a stable double-stranded panhandle structure in polymerase-free RNPs has important implications for the mechanism of viral transcription and the switch from transcription to replication.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135141      PMCID: PMC1169723          DOI: 10.1093/emboj/16.6.1248

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

1.  Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5' capped end.

Authors:  A R Beaton; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

2.  Isolation and characterization of the ribonucleoprotein of influenza virus.

Authors:  M W Pons; I T Schulze; G K Hirst; R Hauser
Journal:  Virology       Date:  1969-10       Impact factor: 3.616

3.  Specific labeling of 3' termini of RNA with T4 RNA ligase.

Authors:  T E England; A G Bruce; O C Uhlenbeck
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  Studies on the helical nucleocapsid of influenza virus.

Authors:  M H Heggeness; P R Smith; I Ulmanen; R M Krug; P W Choppin
Journal:  Virology       Date:  1982-04-30       Impact factor: 3.616

5.  5' and 3' terminal nucleotide sequences of the RNA genome segments of influenza virus.

Authors:  J S Robertson
Journal:  Nucleic Acids Res       Date:  1979-08-24       Impact factor: 16.971

6.  Nucleotide sequences at the 5' termini of influenza virus RNAs and their transcripts.

Authors:  J J Skehel; A J Hay
Journal:  Nucleic Acids Res       Date:  1978-04       Impact factor: 16.971

7.  Assembly of influenza ribonucleoprotein in vitro using recombinant nucleoprotein.

Authors:  D W Kingsbury; I M Jones; K G Murti
Journal:  Virology       Date:  1987-02       Impact factor: 3.616

8.  Pestivirus NS3 (p80) protein possesses RNA helicase activity.

Authors:  P Warrener; M S Collett
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

9.  The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity.

Authors:  U Desselberger; V R Racaniello; J J Zazra; P Palese
Journal:  Gene       Date:  1980-02       Impact factor: 3.688

10.  Chemical probes for higher-order structure in RNA.

Authors:  D A Peattie; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

View more
  92 in total

1.  Three-dimensional reconstruction of a recombinant influenza virus ribonucleoprotein particle.

Authors:  J Martín-Benito; E Area; J Ortega; O Llorca; J M Valpuesta; J L Carrascosa; J Ortín
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

2.  Identification of amino acid residues of influenza virus nucleoprotein essential for RNA binding.

Authors:  D Elton; L Medcalf; K Bishop; D Harrison; P Digard
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins.

Authors:  M Bui; E G Wills; A Helenius; G R Whittaker
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Structure of the RNA inside the vesicular stomatitis virus nucleocapsid.

Authors:  F Iseni; F Baudin; D Blondel; R W Ruigrok
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

5.  Mutagenic analysis of the 5' arm of the influenza A virus virion RNA promoter defines the sequence requirements for endonuclease activity.

Authors:  M B Leahy; D C Pritlove; L L Poon; G G Brownlee
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  Activation of influenza virus RNA polymerase by the 5' and 3' terminal duplex of genomic RNA.

Authors:  M-T Michael Lee; Klaus Klumpp; Paul Digard; Laurence Tiley
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

7.  Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication.

Authors:  Tsai-Ling Liao; Chung-Yi Wu; Wen-Chi Su; King-Song Jeng; Michael M C Lai
Journal:  EMBO J       Date:  2010-10-05       Impact factor: 11.598

8.  3D structure of the influenza virus polymerase complex: localization of subunit domains.

Authors:  Estela Area; Jaime Martín-Benito; Pablo Gastaminza; Eva Torreira; José M Valpuesta; José L Carrascosa; Juan Ortín
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

9.  Chemical modification of nucleotide bases and mRNA editing depend on hexamer or nucleoprotein phase in Sendai virus nucleocapsids.

Authors:  Frédéric Iseni; Florence Baudin; Dominique Garcin; Jean-Baptiste Marq; Rob W H Ruigrok; Daniel Kolakofsky
Journal:  RNA       Date:  2002-08       Impact factor: 4.942

10.  Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2).

Authors:  Hatice Akarsu; Wilhelm P Burmeister; Carlo Petosa; Isabelle Petit; Christoph W Müller; Rob W H Ruigrok; Florence Baudin
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.